NO20041212L - Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav. - Google Patents

Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav.

Info

Publication number
NO20041212L
NO20041212L NO20041212A NO20041212A NO20041212L NO 20041212 L NO20041212 L NO 20041212L NO 20041212 A NO20041212 A NO 20041212A NO 20041212 A NO20041212 A NO 20041212A NO 20041212 L NO20041212 L NO 20041212L
Authority
NO
Norway
Prior art keywords
preparation
growth factor
cocktail composition
autologous growth
factor cocktail
Prior art date
Application number
NO20041212A
Other languages
English (en)
Inventor
Samuel Simon Asculai
Ming Hao Zheng
Original Assignee
Verigen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verigen Ag filed Critical Verigen Ag
Publication of NO20041212L publication Critical patent/NO20041212L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20041212A 2001-09-24 2004-03-23 Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav. NO20041212L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32445301P 2001-09-24 2001-09-24
PCT/US2002/030343 WO2003026689A1 (en) 2001-09-24 2002-09-24 Autologous growth factor cocktail composition, method of production and use

Publications (1)

Publication Number Publication Date
NO20041212L true NO20041212L (no) 2004-05-10

Family

ID=23263651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041212A NO20041212L (no) 2001-09-24 2004-03-23 Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav.

Country Status (15)

Country Link
US (1) US20030144197A1 (no)
EP (1) EP1438067A4 (no)
JP (1) JP2005521633A (no)
KR (1) KR20040053137A (no)
CN (1) CN1592635A (no)
BR (1) BR0212757A (no)
CA (1) CA2460780A1 (no)
HU (1) HUP0501114A2 (no)
IL (1) IL160883A0 (no)
MX (1) MXPA04002716A (no)
NO (1) NO20041212L (no)
PL (1) PL371977A1 (no)
RU (1) RU2004112543A (no)
WO (1) WO2003026689A1 (no)
ZA (1) ZA200402055B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0896825B1 (en) 1997-08-14 2002-07-17 Sulzer Innotec Ag Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors
US6755863B2 (en) * 1999-10-08 2004-06-29 Bret A. Ferree Rotator cuff repair using engineered tissues
US7435260B2 (en) * 1999-08-13 2008-10-14 Ferree Bret A Use of morphogenetic proteins to treat human disc disease
EP1531855A4 (en) 2002-01-10 2009-07-22 Osteotrophin Llc TREATMENT OF BONE DISEASES WITH SKELETTAL ANABOLIKA
US20040136968A1 (en) 2002-09-27 2004-07-15 Verigen Ag Autologous cells on a support matrix for tissue repair
JP2005060307A (ja) * 2003-08-12 2005-03-10 Pirumu:Kk 骨造成剤
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
NZ571913A (en) * 2006-03-23 2011-11-25 Univ Western Australia Tenocyte cell culturing method
WO2008031196A1 (en) * 2006-09-13 2008-03-20 Enhance Skin Products, Inc. Treatment of aged skin with autologous growth factors in a hyaluronic acid delivery system
WO2008128342A1 (en) * 2007-04-18 2008-10-30 Mcgill University Composition for enhancing bone formation
US8513193B2 (en) 2008-10-13 2013-08-20 University Of Rochester Protecting and repairing cartilage and musculoskeletal soft tissues
JP2012506733A (ja) * 2008-10-24 2012-03-22 ウォーソー・オーソペディック・インコーポレーテッド 骨形成を促進するための組成物および方法
KR101288587B1 (ko) * 2011-07-12 2013-08-22 휴먼바이오텍 주식회사 줄기세포로부터 분비된 성장 인자의 대량 분리 및 농축 방법
US20140141047A1 (en) * 2012-11-19 2014-05-22 Wisconsin Alumni Research Foundation Selection of platelet rich plasma components via mineral binding

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
WO1992009697A1 (en) * 1990-11-30 1992-06-11 Celtrix Laboratories, Inc. USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-β FOR BONE REPAIR
US6413511B1 (en) * 1990-12-20 2002-07-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide
ZA923086B (en) * 1991-04-29 1993-10-28 South African Medical Research A delivery system for biologicaly active growth or morphogenetic factors and a method for preparing such delivery system
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5837258A (en) * 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
JP3585180B2 (ja) * 1993-05-11 2004-11-04 三菱化学株式会社 新規なヒトタンパク質およびそれをコードする遺伝子
US5989269A (en) * 1996-08-30 1999-11-23 Vts Holdings L.L.C. Method, instruments and kit for autologous transplantation
AU2002339601A1 (en) * 2001-03-30 2002-12-03 Verigen Ag Method for certifying chondrocytes for use in cartilage regeneration

Also Published As

Publication number Publication date
IL160883A0 (en) 2004-08-31
RU2004112543A (ru) 2005-03-27
CN1592635A (zh) 2005-03-09
ZA200402055B (en) 2005-06-22
CA2460780A1 (en) 2003-04-03
US20030144197A1 (en) 2003-07-31
WO2003026689A1 (en) 2003-04-03
BR0212757A (pt) 2004-10-13
JP2005521633A (ja) 2005-07-21
EP1438067A1 (en) 2004-07-21
HUP0501114A2 (en) 2007-11-28
PL371977A1 (en) 2005-07-11
WO2003026689A8 (en) 2004-06-10
MXPA04002716A (es) 2005-11-08
KR20040053137A (ko) 2004-06-23
EP1438067A4 (en) 2006-06-14

Similar Documents

Publication Publication Date Title
NO331093B1 (no) Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav.
PT2308888T (pt) Anticorpos anti-il-6, composições, métodos e utilizações
IS6531A (is) Aðferðir til að búa til klaríþrómýsín og klaríþrómýsínmilliefni, í megindráttum oxímlaust klaríþrómýsín og lyfjablanda sem inniheldur það
NO20041212L (no) Autolog vekstfaktor-cocktail sammensetning, fremgangsmate for fremstilling og anvendelse derav.
IS7188A (is) Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
EE05223B1 (et) Triasoloprimidiini hendid, meetod nende valmistamiseks ning nende kasutamine
EE200200704A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
IS7226A (is) Fjölbrigða form af rimonabant, framleiðsluaðferð og lyfjasamsetningar sem innihalda það
EE200300400A (et) Pürimidiiniühendid, nende valmistamismeetod ning kasutamine
DK1385826T3 (da) Fremgangsmåde til fremstilling af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azapin-5-carboxamid
DK1949936T3 (da) Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf
EE200100653A (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
AU2003286474A8 (en) Compositions, solutions, and methods used for transplantation
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
HUP0402602A3 (en) Method for preparing echinocandin derivatives, their use, pharmaceutical compositions comprising thereof and their intermediates
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
AU2002245510A1 (en) Method and composition for embalming
FI20020088L (fi) Menetelmä kasvislignaanien valmistamiseksi ja uusi välituote
DE60139633D1 (de) Transformierender wachstumsfaktor alpha enthaltende impfstoffzusammensetzung
GB0115204D0 (en) Ceramic materials, method for their production and use thereof
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
NO20034581D0 (no) Fremgangsmåte for autolog transplantasjon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application